Geron
GERN
#6101
Rank
NZ$1.71 B
Marketcap
NZ$2.68
Share price
2.60%
Change (1 day)
11.46%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -NZ$87.54 Million

According to Geron's latest financial reports the company's current earnings are NZ$0.18 Billion. , an increase over its 2024 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$86.17 Million-67.42%
2024 -NZ$0.27 Billion-11.23%
2023 -NZ$0.3 Billion30.22%
2022 -NZ$0.23 Billion20.15%
2021 -NZ$0.2 Billion50.08%
2020 -NZ$0.13 Billion4.46%
2019 -NZ$0.13 Billion130.68%
2018 -NZ$52.67 Million8.84%
2017 -NZ$48.39 Million-3.08%
2016 -NZ$49.92 Million-22080.6%
2015 NZ$0.22 M-100.38%
2014 -NZ$60.32 Million-7.14%
2013 -NZ$64.95 Million
2011 -NZ$0.16 Billion19.04%
2010 -NZ$0.13 Billion8.45%
2009 -NZ$0.12 Billion-2.51%
2008 -NZ$0.13 Billion14.65%
2007 -NZ$0.11 Billion32.68%
2006 -NZ$80.27 Million25.59%
2005 -NZ$63.92 Million4.36%
2004 -NZ$61.25 Million19.73%
2003 -NZ$51.15 Million-15.46%
2002 -NZ$60.51 Million1.94%
2001 -NZ$59.36 Million33.59%
2000 -NZ$44.43 Million27.53%
1999 -NZ$34.84 Million63.13%
1998 -NZ$21.36 Million15.6%
1997 -NZ$18.48 Million-10.66%
1996 -NZ$20.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$16.60 B-19,369.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$2.82 B-3,373.71%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion 36.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.20 B-342.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.09 Million-81.34%๐Ÿ‡บ๐Ÿ‡ธ USA